Third-party verification
Clinical Trial Report on Dentin Hypersensitivity
In 2025, a toothpaste containing 5% calcium phosphosilicate developed by Azalli showed results from human clinical trials conducted by the professional research institution, The School and Hospital of Stomatology, Fujian Medical University.
The trials demonstrated that using the test toothpaste with 5% calcium phosphosilicate twice daily provided dentin hypersensitivity relief after 2 weeks, with improved efficacy after 6 weeks.
The 7th Shanghai International Personal Care Expo (PCE)
In the same year, we took part in the 7th Shanghai International Personal Care Expo (PCE). During the event, in-depth communications were conducted with brand partners focusing on product efficacy verification and order cooperation. Through targeted publicity and promotion, we successfully solved the problems that customers concerned about, including the filing of anti-sensitive products and the standardized promotion of relevant clinical reports.
